Tycho W. Peterson

In separate reports, JPMorgan’s Tycho W. Peterson initiated coverage of both INC Research Holdings Inc (NASDAQ: INCR) and Accelerate Diagnostics Inc (NASDAQ: AXDX) with Overweight ratings, with price targets of $47 and $17, respectively. INC Research The company is a leader in the...

Varian Medical Systems, Inc. (NYSE: VAR)'s recently lowered revenue outlook from pressure exerted by a strong dollar will weigh on the company's shares over the near-to-intermediate term, an analyst said Thursday. JP Morgan's Tycho W. Peterson downgraded the Palo Alto-based medical...

In a report published Tuesday, J.P. Morgan analyst Tycho W. Peterson initiated coverage on Catalent Inc (NYSE: CTLT) with an Overweight rating and $28.00 price target. In the report, J.P. Morgan noted, “We are initiating coverage on Catalent (CTLT) with an Overweight rating and December 2015 PT of...

In a report published Tuesday, J.P. Morgan analyst Tycho W. Peterson initiated coverage on Albany Molecular Research, Inc. (NASDAQ: AMRI) with an Overweight rating and $25.00 price target. In the report, J.P. Morgan noted, “We are initiating coverage on Albany Molecular Research (AMRI) with an...

J.P. Morgan analyst Tycho Peterson reinstated an Underweight rating and $25.00 price target on Myriad Genetics Inc. (NASDAQ: MYGN) following the period of restriction related to the $270 million acquisition of Crescendo. Peterson commented, "Our concerns over the longer-term outlook for pricing...

In a report published Friday, J.P. Morgan analyst Tycho W. Peterson upgraded the rating on Accuray (NASDAQ: ARAY) from Underweight to Neutral, and reiterated the $8.00 price target. In the report, J.P. Morgan noted, “We are upgrading Accuray (ARAY) from Underweight to Neutral, as the company has...

In a report published Monday, J.P. Morgan analyst Tycho W. Peterson initiated coverage on Cellular Dynamics International (NASDAQ: ICEL) with an Overweight rating and $18.00 price target. In the report, J.P. Morgan noted, “We are initiating coverage on Cellular Dynamics International (ICEL) with...

In a report published Monday, J.P. Morgan analyst Tycho W. Peterson initiated coverage on NanoString Technologies (NASDAQ: NSTG) with an Overweight rating and $14.00 price target. In the report, J.P. Morgan noted, “We are initiating coverage of NanoString (NSTG) with an Overweight rating and...

In a report published Monday, J.P. Morgan analyst Tycho W. Peterson maintained an Overweight rating on GenMark Diagnostics (NASDAQ: GNMK) and lowered the price target from $17 to $15. In the report, J.P. Morgan cited their price target decrease to news that, “GenMark officially lowered 2013...

In a report published Tuesday, J.P. Morgan analyst Tycho W. Peterson initiated coverage on Quintiles Transnational (NYSE: Q) with an Overweight rating and $50.00 price target. In the report, J.P. Morgan noted, “We are initiating coverage on Quintiles (Q) with an Overweight rating and December...